Show Archives
Fox In The Chicken House
May 24, 2022
Chicago attorney, Brendan Cournane, leads off discussing his time as a marathon runner, stocks on a downward trajectory, and Elon Musk’s acquisition of Twitter. Joel Elconin of Benzinga talks gas price spikes, social media stocks, and inflation volatility. Kenny Polcari, Managing Principal at ButcherJoseph Asset Management, LLC and a contributor to Fox Business, joins us to talk trends in the market, New York’s last pay phone, and Amazon’s long-term stock value. Westminster Professor of Economics, Dr. Hal Snarr, closes the show to speak on Snapchat’s put drop, financial kick backs to the Fed, the national deficit, how inflation is creating personal recessions amongst the middle class, and much more.
Those Were The Days
May 23, 2022
AG market watcher Greg Pappas leads off our first hour on politics, inflation and more. John Flannigan jumps in for our second hour to talk on taxes under the Biden administration, Covid-19 vaccines and the morality of theft. Finally, Audrey Johnson joins in for our last half hour to discuss the housing market, bonds and investing in your neighborhoods.
Aces High
May 20, 2022
Kevin O’Neill leads off for hour one talking on China, health insurance and Notre Dame football. Karl Denninger of Market Ticker calls in for hour two to talk of reflections on the U.S-Vietnam war draft, corporate investment in government and the logistics of green energy.
The Big Repricing
May 19, 2022
Lou Michels leads off for hour one talking Elon Musk, the baby formula shortage, and much more. Dan Johnedis, President & CIO of Cratus Capital LLC, talks yesterday’s market collapse driven by large retailers before sharing some stock recommendations. Russell Rhoads makes a rare Thursday appearance to talk Bitcoin, inflation drivers, and tax policy.
Short The Straddle
May 18, 2022
Kevin O’Neill leads off for hour one talking baseball, stock market trends, supply chain shortages, and much more. John Flannigan takes over for our second hour to talk inflation volatility, Target’s massive drop in shares, supply chain concerns, option premiums, and more.